From October 1, 2023 to December 19, 2023, the company has repurchased 2,412,900 shares, representing 0.2% for CNY 38 million. With this, the company has completed the repurchase of 2,412,900 shares, representing 0.2% for CNY 38 million under the buyback announced on August 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.36 CNY | +0.68% | -1.11% | -9.61% |
May. 14 | Yifan Pharmaceutical Unit Gets Authorization to Sell Circulation Supplement in Singapore | MT |
Apr. 25 | Yifan Unit's Allergy Drug Passes China Regulatory Test, Stock Price Jumps | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.61% | 2.24B | |
+16.03% | 41.97B | |
+22.56% | 22.34B | |
+15.82% | 15.25B | |
+16.34% | 14B | |
+50.00% | 12.06B | |
-10.77% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- 002019 Stock
- News Yifan Pharmaceutical Co., Ltd.
- Tranche Update on Yifan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 31, 2023.